Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Eucomed: The European medical technology industry association approved a new board of directors April 13. Guy Lebeau, Johnson & Johnson's Medical Device and Diagnostics company group chairman for Europe, Middle East and Africa, was reelected as chairman. Alain Coudray, Medtronic's VP for Cardiac Rhythm Disease Management, Europe and Central Asia, is the new vice chairman. The board is composed of 15 members, including five corporate representatives and seven representatives of individual European country associations

You may also be interested in...



People Briefs: Changes At Eucomed; McClellan Joins J&J Board; Hires At Three Firms

Changes announced at European trade groups Eucomed, MedTech Europe as Guy Lebeau steps down from leadership posts; former FDA Commissioner Mark McClellan joins J&J board. More personnel news.

People In Brief

J&J regulatory affairs: Robert O'Holla retires in April from his position as VP-regulatory affairs for Johnson & Johnson's device and diagnostics segments after more than 30 years with the company. O'Holla has held his current position since 1990. Dorothy Clarke has been transitioning to fill his role since February, with the new title of VP-regulatory affairs for the Comprehensive Care and Surgical Care units, housing most of J&J's device businesses following a restructuring last November (1"The Gray Sheet" Nov. 19, 2007, p. 11). Clarke was previously a legal VP at Ethicon and assistant general counsel for the J&J device and diagnostics legal group

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028766

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel